Market Place
Sourcing Support
Precision Bio Grants Inducement Awards Under Nasdaq Rule
24 Apr 2026 //
BUSINESSWIRE
Precision BioSciences to Participate in Healthcare Conference
08 Apr 2026 //
BUSINESSWIRE
Precision Biosciences Reports Fourth Quarter & Fiscal Year Result
12 Mar 2026 //
BUSSINESSWIRE
Precision Biosciences Receives U.S. Patent Allowances Covering
11 Mar 2026 //
BUSSINESSWIRE
Precision Biosciences Presents Preclinical PBGENE-DMD Data
10 Mar 2026 //
BUSSINESSWIRE
Precision Biosciences Receives FDA Fast Track Designation
09 Mar 2026 //
BUSSINESSWIRE
Precision Biosciences To Report Fourth Quarter And Fiscal Year
09 Mar 2026 //
BUSSINESSWIRE
Precision BioSciences Grants Inducements Under Nasdaq Listing
23 Dec 2025 //
BUSINESSWIRE
Precision Biosciences To Release Q3 2025 Financial Results
31 Oct 2025 //
BUSINESSWIRE
Precision BioSciences Q2 2025 Financial Results & Business Update
07 Aug 2025 //
BUSINESSWIRE
Precision Bio to Report Second Quarter 2025 Results on August 7
04 Aug 2025 //
BUSINESSWIRE
Precision BioSciences Announces Grant of Inducement Awards
29 Apr 2025 //
BUSINESSWIRE
Precision BioSciences Reports Q4 2024 Results and Business Update
26 Mar 2025 //
BUSINESSWIRE
Precision BioSciences to Report Q4 and FY 2024 Results on March
21 Mar 2025 //
BUSINESSWIRE
Precision BioSciences to Join H.C. Wainwright 26th Annual Healthcare Conference
04 Sep 2024 //
BUSINESSWIRE
Precision BioSciences to Report Second Quarter Results on August 1, 2024
29 Jul 2024 //
BUSINESSWIRE
Precision BioSciences Announces its Addition to the Russell Microcap® Index
01 Jul 2024 //
BUSINESSWIRE
Precision BioSciences Announces Presentation at UMDF Mitochondrial Medicine 2024
27 Jun 2024 //
BUSINESSWIRE
Precision BioSciences Adds Top Experts To Hepatitis Advisory Board
20 Jun 2024 //
BUSINESSWIRE
Precision BioSciences to Participate in Upcoming June Investor Conferences
30 May 2024 //
BUSINESSWIRE
Precision Bio Reports Q1 2024 Results, Business Update
13 May 2024 //
BUSINESSWIRE
Precision BioSciences: Management Stock Purchase
08 May 2024 //
BUSINESSWIRE
Precision BioSciences to Report First Quarter Results on May 13, 2024
07 May 2024 //
BUSINESSWIRE
Precision Bio Regains Programs, Ends Prevail Collaboration
16 Apr 2024 //
BUSINESSWIRE
Precision Reports Fourth Quarter and Fiscal Year 2023 Financial Results
27 Mar 2024 //
BUSINESSWIRE
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results
20 Mar 2024 //
BUSINESSWIRE
Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM
19 Mar 2024 //
BUSINESSWIRE
Precision BioSciences Announces MHRA Approval for Partner iECURE
06 Mar 2024 //
BUSINESSWIRE
Precision Bio Announces $40.0 Million Offering of Common Stock and Warrants
01 Mar 2024 //
BUSINESSWIRE
Precision Bio Announces Proposed Public Offering of Common Stock and Warrants
29 Feb 2024 //
BUSINESSWIRE
Precision BioSciences Announces Proposed Public Offering of Common Stock
29 Feb 2024 //
PRESS RELEASE
Precision Announces Non-Exclusive Patent License Agreement with Caribou
20 Feb 2024 //
BUSINESSWIRE
Precision Bio Promotes Naresh Tanna to Vice President of Investor Relations
13 Feb 2024 //
BUSINESSWIRE
Precision Bio Receives Initial $7.5 Million Cash Payment from TG Therapeutics
12 Feb 2024 //
BUSINESSWIRE
Precision BioSciences to Effect a Reverse Stock Split
09 Feb 2024 //
PRESS RELEASE
TG Therapeutics Announces Global License Agreement with Precision BioSciences
09 Jan 2024 //
GLOBENEWSWIRE
Precision Announces Approval of First Trial Application of Gene Insertion Program
13 Dec 2023 //
BUSINESSWIRE
Precision BioSciences to Present at Hep-DART 2023
30 Nov 2023 //
BUSINESSWIRE
Precision Announces Grant of Inducement Award Under Nasdaq Listing 5635(c)(4)
28 Nov 2023 //
BUSINESSWIRE
Precision BioSciences to Present at Upcoming Sidoti Conference
10 Nov 2023 //
BUSINESSWIRE
Precision BioSciences Announces Late-Breaking Poster Presentation
09 Nov 2023 //
BUSINESSWIRE
Precision BioSciences Reports Third Quarter 2023 Financial Results
07 Nov 2023 //
BUSINESSWIRE
Precision Bio Presents Preclinical Data Highlighting Capabilities of ARCUS
26 Oct 2023 //
BUSINESSWIRE
Precision to Present at H.C. Wainwright 4th Annual Hepatitis B Virus Conference
23 Oct 2023 //
BUSINESSWIRE
Precision BioSciences to Present at the ESGCT 30th Annual Congress
12 Oct 2023 //
BUSINESSWIRE
Precision BioSciences Receives U.S. Patent Allowance Covering PBGENE-PMM
27 Sep 2023 //
BUSINESSWIRE
Precision Bio to Attend and Present at Upcoming September Investor Conferences
06 Sep 2023 //
BUSINESSWIRE
Precision Bio Completes Transaction with Imugene for Azer-Cel in Cancer
15 Aug 2023 //
BUSINESSWIRE
Precision BioSciences Reports Second Quarter 2023 Financial Results
04 Aug 2023 //
BUSINESSWIRE
Precision BioSciences to Report Second Quarter Results on August 4, 2023
01 Aug 2023 //
BUSINESSWIRE
Precision BioSciences Provides Updates on Azer-Cel FDA Meeting
27 Jul 2023 //
BUSINESSWIRE
Precision BioSciences Reports1Q 2023 FYR and Provides Business Update
09 May 2023 //
BUSINESSWIRE
Precision Receives Patent Allowances for Proprietary PCSK9 ARCUS Nuclease
13 Apr 2023 //
BUSINESSWIRE
Precision to Participate in Upcoming Guggenheim Healthcare Talks Conference
27 Mar 2023 //
BUSINESSWIRE
Precision Announces Senior Leadership Promotions and Organizational Changes
24 Feb 2023 //
BUSINESSWIRE
Precision BioSciences Recaps 2022 Accomplishments
09 Jan 2023 //
BUSINESSWIRE
Precision BioSciences Announces Change to its Board of Directors
10 Nov 2022 //
BUSINESSWIRE
Precision BioSciences Reports3Q 2022 Financial Results and Provides Update
08 Nov 2022 //
PRESS RELEASE
Precision Announces Presentation on Attributes of CD19 Allogeneic CAR T,Azer-Cel
03 Nov 2022 //
BUSINESSWIRE
